Author: Zacks Small Cap Research

1234568640 / 851 POSTS
By John Vandermosten, CFANASDAQ:HTBX READ THE FULL HTBX RESEARCH REPORT Full Year 2019 Results Heat Biologics, Inc. (NASDAQ:HTBX) reported first quarter 2020 results in a May 15th release along with the submission of the 10-Q to the SEC. For the fir ...
By John Vandermosten, CFANASDAQ:AZRX READ THE FULL AZRX RESEARCH REPORT On May 15th, 2020, AzurRx BioPharma, Inc. (NASDAQ:AZRX) filed its first quarter 2020 10-Q with the SEC for the three month period ending March 31, 2020. Highlights year to date i ...
By John Vandermosten, CFANASDAQ:TENX READ THE FULL TENX RESEARCH REPORT First Quarter 2020 Financial and Operational Review Tenax Therapeutics, Inc. (NASDAQ:TENX) completed enrollment of its Hemodynamic Evaluation of Levosimendan in Patients with PH- ...
By John Vandermosten, CFANASDAQ:TTNP READ THE FULL TTNP RESEARCH REPORT Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) has been working hard to set up the ecosystem required for successful commercialization of Probuphine. The company has expanded its dist ...
By David Bautz, PhDNASDAQ:CFRX READ THE FULL CFRX RESEARCH REPORT Business Update Four Abstracts Published in 30th ECCMID Abstract Book On May 11, 2020, ContraFect Corp. (NASDAQ:CFRX) announced four abstracts were published in the 30th European Congr ...
By John Vandermosten, CFANASDAQ:DYAI READ THE FULL DYAI RESEARCH REPORT First Quarter Financial & Operational Results Dyadic International Inc. (NASDAQ: DYAI) released first quarter financial and operational results on May 14, 2020. Revenues wer ...
By John Vandermosten, CFANASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT First Quarter 2020 Review Achieve Life Sciences, Inc. (NASDAQ:ACHV) reported first quarter results in an early morning press release and conference call held on May 14th 2020. Th ...
By John Vandermosten, CFANASDAQ:PHIO READ THE FULL PHIO RESEARCH REPORT Milestones: ‣ Partnership/Sale of Dermatology and Ophthalmology Programs – TBD ‣ Expansion of collaboration with Helmholtz Zentrum München & Medigene – March 2020 ‣ IND enabl ...
By Ian Gilson, PhD, CFANASDAQ:UHAL READ THE FULL UHAL RESEARCH REPORT AMERCO (NASDAQ:UHAL) reported its fourth quarter and annual results for fiscal 2020 (ending on March 31, 2020) on May 27, 2020 with a follow-up on May 28, 2020. Management stated t ...
By John VandermostenNYSE:CVM READ THE FULL CVM RESEARCH REPORT Second Quarter Fiscal Year 2020 Operational and Financial Results CEL-SCI Corporation (NYSE:CVM) reported second quarter fiscal year 2020 operational and financial results for the three m ...
1234568640 / 851 POSTS